Skip to content

Author

Medidi Srinivas

We have 2 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Quinoxaline Derivatives As Anticancer Agents: Molecular Targets And SAR

Overall, quinoxaline represents a flexible platform for developing multifunctional and target-directed anticancer agents with potential applications across diverse cancer-associated pathways.

Racha Umadevi, K. Sujatha, Medidi Srinivas · 0 citations
Open access Jul 2026

SYNTHESIS, MOLECULAR DOCKING, AND ANTICANCER ACTIVITY OF NOVEL COUMARIN DERIVATIVES

Overall, C1 emerged as the most promising lead for further optimization as a multitarget anticancer agent, while C2 and C3 provide complementary scaffolds for future medicinal chemistry and mechanistic investigations.

D. Thangamani, Medidi Srinivas, S. Begum et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.